These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 6773320)

  • 1. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran.
    Mahdavi-Mazdeh M; Zamyadi M; Norouzi S; Heidary Rouchi A
    Iran J Kidney Dis; 2007 Jul; 1(1):25-8. PubMed ID: 19357440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
    Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
    Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phosphorus and calcium metabolism and its hormonal regulation in chronic kidney failure].
    Nikiforova NV; Strunin SE; Ermolenko VM; Mozzhechkov VT; Khomiakova VN
    Ter Arkh; 1985; 57(1):103-7. PubMed ID: 3983831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 7. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric acid secretion and calcium metabolism in patients with chronic hemodialysis].
    Fendler JP; Khazine F; Dongradi G; Cassan P; Beaugrand M; Salmon D
    J Urol Nephrol (Paris); 1978 Sep; 84(9):658-63. PubMed ID: 748587
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
    Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
    Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
    J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antagonism of parathyroid hormone by calcitonin].
    Garrido M; Jiménez J; Damiano A; Macías A; Betancor P
    Rev Iber Endocrinol; 1970; 17(101):377-89. PubMed ID: 5501995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumor calcinosis in chronic renal insufficiency].
    Caballero P; Reyes R; Quirós J; Macarrón P; Lara T
    Rev Clin Esp; 1986 Jul; 179(3):138-41. PubMed ID: 3763993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parathormone and calcitonin in the blood in chronic kidney diseases].
    Mosin VM; Iagoda AV; Salanda BS; Derevianko NA
    Ter Arkh; 1982; 54(7):82-4. PubMed ID: 7135230
    [No Abstract]   [Full Text] [Related]  

  • 15. CKD-MBD: comfort in the trough of the U.
    Cunningham J; Silver J
    Nephrol Dial Transplant; 2011 Jun; 26(6):1764-6. PubMed ID: 21551089
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
    Slinin Y; Foley RN; Collins AJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
    Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
    Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
    Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
    Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.